Kidney Replacement Therapy clinical trials

Explore recruiting kidney replacement therapy clinical trials.

Recruiting kidney replacement therapy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kidney Replacement Therapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN patients with moderate to severe chronic Kidney disease: an open label, cluster randomized controlled, phase 3 trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

CLEOPATTRA: Effects of NNC6019-0001 versus placebo on cardiovascular outcomes in participants with transthyretin amyloid cardiomyopathy (ATTR-CM).

Germany, France, Belgium, Italy, Denmark, Netherlands +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluating the clinical effectiveness of sodium bicarbonate for critically ill patients with metabolic acidosis and acute kidney injury

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Discontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)

Sweden, Denmark, Ireland, Austria, Iceland, Netherlands +1 more

Therapeutic use (Phase IV) EU CTIS Study details

Imlifidase in ANCA-associated Vasculitis

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

The cardiovascular safety and efficacy of cagrilintide 2.4 mg s.c. in combination with semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) once-weekly in participants with established cardiovascular disease

France, Ireland, Netherlands, Poland, Denmark, Bulgaria +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Kidney Replacement Therapy trials by city

Kidney Replacement Therapy in Toronto Kidney Replacement Therapy in Vancouver Kidney Replacement Therapy in Montreal Kidney Replacement Therapy in Calgary Kidney Replacement Therapy in Edmonton Kidney Replacement Therapy in Ottawa Kidney Replacement Therapy in Winnipeg Kidney Replacement Therapy in Quebec City Kidney Replacement Therapy in Hamilton Kidney Replacement Therapy in Kitchener Kidney Replacement Therapy in London Kidney Replacement Therapy in Halifax Kidney Replacement Therapy in New York Kidney Replacement Therapy in Los Angeles Kidney Replacement Therapy in Chicago Kidney Replacement Therapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease